Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Rheumatoid nodule
ADR ID BADD_A04716
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.06      Rheumatoid arthritis and associated conditions
10.04.06.002      Rheumatoid nodule
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.04      Skin and subcutaneous conditions NEC
23.07.04.004      Rheumatoid nodule
15      Musculoskeletal and connective tissue disorders
15.01      Joint disorders
15.01.03      Rheumatoid arthropathies
15.01.03.002      Rheumatoid nodule
Description Subcutaneous nodules seen in 20-30% of rheumatoid arthritis patients. They may arise anywhere on the body, but are most frequently found over the bony prominences. The nodules are characterized histologically by dense areas of fibrinoid necrosis with basophilic streaks and granules, surrounded by a palisade of cells, mainly fibroblasts and histiocytes. [MeSH]
MedDRA Code 10048694
MeSH ID D012218
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Rheumatoid nodule | Accelerated nodulosis | Rheumatoid Nodule | Nodule, Rheumatoid | Nodules, Rheumatoid | Rheumatoid Nodules | Rheumatoid Nodulosis | Rheumatoid Noduloses
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01418Methotrexate0.004605%
BADD_D01419Methotrexate sodium--
BADD_D01834Prednisone0.000009%
BADD_D02093Sulfasalazine--
BADD_D02236Tofacitinib0.007764%
BADD_D02375Water--
The 1th Page    1    Total 1 Pages